More answers like this
GPT-5Oct 8, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Short answer: yes—targeted, conditional pauses and sensible restrictions make sense; an open‑ended blanket pause does not.
How to think about it
•Separate research from deployment. Most risks scale with access and real‑world integration, not with lab experiments. Default to stronger controls at deployment time.
•Be risk‑based. Treat calculators, tutors, and coding assistants differently from systems that can meaningfully aid cyber offense, bioengineering, or critical‑infrastructure disruption.
•Require a “safety case.” Like aviation, make developers show evidence that a system is acceptably safe for its intended use before broad release.
When a pause is justified
•Capability red flags: Evaluations show dangerous autonomy, targeted persuasion at scale, or materially improved ability to plan or carry out prohibited harm (e.g., actionable wet‑lab protocols, zero‑day exploitation). Pause until mitigations close the gap.
•Scale thresholds: Training runs above a defined compute/model‑size bar should trigger a stop‑and‑review (third‑party audit, adversarial testing, security hardening) before continuing.
•Incident response: After serious misuse or safety failures, pause further rollout or scaling while issues are remediated.
What to restrict (concretely)
•Access to high‑risk tools and interfaces: rate limits, identity/KYC for powerful agentic or code‑execution features, and tiered permissions for sensitive domains.
•Model autonomy and integrations: prohibit unsupervised control of money, cloud resources, industrial systems, or lab equipment without strong guardrails, human oversight, and kill‑switches.
•Dual‑use knowledge: filtered outputs; staged disclosure for capabilities that lower barriers to biological, chemical, or cyber harm.
•Frontier development: licensing for the largest training runs; mandatory security (model/data/weights), red‑teaming, independent audits, incident reporting, and post‑deployment monitoring.
•Release practices: phased access, eval‑gated rollouts, content provenance/watermarking, and clear use policies with enforceable penalties.
What not to over‑restrict
•Low‑risk, open academic work; transparency about limitations and eval methods; safety research; tools that primarily improve accessibility, education, healthcare, and scientific discovery.
•Local, on‑device models for benign use cases, provided they can’t be readily repurposed for high‑risk tasks.
Why not a blanket pause
•Hard to coordinate or verify globally; risks pushing development to less accountable actors.
•Freezes beneficial progress (e.g., safety techniques, interpretability, defense) along with risky capability growth.
•Blunt tool for a problem that varies widely by application and model.
Practical policy bundle that balances progress and safety
•Compute‑tiered oversight: escalating obligations as training resources/capabilities increase.
•Pre‑deployment evals tied to go/no‑go gates; publish eval suites and residual‑risk summaries.
•Independent audits and red‑team reports for high‑impact systems.
•Secure development lifecycle and model weight protection.
•Post‑deployment monitoring, incident disclosure, and rapid rollback plans.
•Targeted access controls for high‑risk features; stronger identity requirements where misuse costs are high.
•Public investment in safety research, benchmarks, and defensive uses of AI.
•Workforce transition support and competition policy to avoid excessive concentration of power.
If you’d like, tell me which risks worry you most (misinformation, cyber, bio, job loss, long‑term catastrophe, something else) and what context you care about (consumer apps, enterprise, government). I can turn this into a concrete, prioritized policy or product‑safety plan.